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Disturbed Ca2+-signaling by chloroacetaldehyde: A possible
cause for chronic ifosfamide nephrotoxicity.
Background. Renal damage following chemotherapy with
ifosfamide is attributed to the metabolic activation of the drug
and the generation of chloroacetaldehyde (CAA). Little is
known about the mechanism by which CAA impairs renal func-
tion. In this study the effect of CAA on intracellular Ca2+
homeostasis in human renal proximal tubule cells (RPTEC)
in primary culture was investigated.
Methods. Intracellular Ca2+ was measured using the Ca2+-
sensitive dye fura-2. Cell viability was determined by protein
content and cell number. Oncotic and apoptotic cell death was
assayed using trypan blue exclusion, caspase-3 activity, and 4′,6-
diamino-2-phenylindole (DAPI) staining.
Results. CAA (1.5 to 150 lmol/L) induced sustained eleva-
tions of intracellular free calcium ([Ca2+]i) from 75 ± 3 nmol/L
to maximal 151 ± 6 nmol/L. This effect was dependent on extra-
cellular Ca2+, but not Ca2+ entry. The rise in [Ca2+]i mediated
by CAA could be attributed to inhibition of Na+-dependent
extrusion of intracellular Ca2+, indicating an inhibitory action
of CAA on Na+/Ca2+ exchange. Modulation of protein kinase
A (PKA), but not protein kinase C (PKC) blunted the effect of
CAA. Thus, CAA seems to inhibit Na+/Ca2+ exchange by in-
teraction with cyclic adenosine monophosphate (cAMP)-PKA-
signaling. A 48-hour exposure to 15 lmol/L CAA significantly
reduced cell number and protein content of RPTEC by in-
duction of necrosis. This effect of 15 lmol/L CAA could be
overcome by coadministration of the intracellular Ca2+ chela-
tor 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid
acetoxymethyl ester (BAPTA-AM).
Conclusion. First, CAA inhibits the Na+/Ca2+-exchanger.
Second, this effect is dependent on PKA. Third, CAA induces
necrotic rather than apoptotic cell death. Finally, disturbed Ca2+
homeostasis via Na+/Ca2+ exchange contributes to the nephro-
toxic action of CAA in RPTEC.
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Ifosfamide is an alkylating agent frequently used in an-
tineoplastic combination therapy to treat solid tumors in
pediatric oncology [1]. Structure and mode of action are
very similar to the elder compound cyclophosphamide [1,
2]. The use of the latter is limited by its greater hematotox-
icity and the occurrence of hemorrhagic cystitis caused by
the urotoxic metabolite acrolein [1–3]. Furthermore ifos-
famide has shown efficacy in cyclophosphamide-resistant
tumors [1, 3]. Despite these advantages ifosfamide ther-
apy exhibits serious side effects. Most prevalent among
these are neurotoxicity and nephrotoxicity, attributed to
the metabolite chloroacetaldehyde (CAA) [4, 5]. Neuro-
toxicity is often transient and resolves after discontinu-
ation of treatment. Nephrotoxicity occurs as acute and
chronic renal damage which persists or even aggravates
after the end of ifosfamide therapy. CAA generation
is significantly greater from ifosfamide as compared to
cyclophosphamide, since approximately 20% to 40% of
ifosfamide undergoes dechloroethylation, whereas only
5% to 10% of cyclophosphamide are metabolized to form
CAA [6–8]. Furthermore, ifosfamide is usually adminis-
tered in higher doses due to reduced hematotoxicity com-
pared to cyclophosphamide [1].
Ifosfamide is a prodrug and requires metabolic acti-
vation by the cytochrome P450 system to form the ac-
tive metabolite ifosforamide mustard and the urotoxic
side product acrolein. Approximately 20% to 40% of
the ifosfamide dose undergoes dechloroethylation to
form 2,3-dechloroethylifosfamide and CAA. Coadminis-
tration of the sulfhydryl-containing compounds, sodium-
2-mercaptoethanesulfonate (MESNA) or amifostine, has
been shown to prevent acrolein-induced hemorrhagic
cystitis accompanying cyclophosphamide and ifosfamide
therapy [4, 9]. Despite effectiveness in cell culture studies,
MESNA seems unable to protect renal damage following
ifosfamide therapy in the clinical setting [10].
Impairment of renal function as a result of ifosfamide
therapy has been shown to be mainly due to loss of proxi-
mal tubular function causing at worst Fanconi’s syndrome
characterized by proteinuria, glucosuria, aminoaciduria,
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and urinary loss of phosphate and electrolytes [9]. The
time course of renal damage in ifosfamide therapy ranges
from acute renal failure to chronic kidney disease which
is sometimes even progressive after discontinuation of
treatment [9]. Thus it is conceivable that development of
nephrotoxicity is rather due to a modulation in cellular
function leading to inflammatory and fibrotic processes
than acute necrosis of tubular cells. This modulation may
occur by interaction of ifosfamide and/or metabolites
with cellular signaling mechanisms leading to altered cel-
lular function finally resulting in organ dysfunction. There
is some evidence for alterations of sodium-dependent
transport mechanisms in renal proximal tubular cells
caused by ifosfamide metabolites as a possible mecha-
nism leading to Fanconi’s syndrome [11, 12].
Intracellular free calcium ([Ca2+]i) is a central cellu-
lar second messenger system. A wide range of cellular
functions like proliferation, differentiation, apoptosis,
and epithelial transport are regulated via [Ca2+]i and
downstream signaling, involving protein kinase C (PKC)
and mitogen-activated protein (MAP) kinases. There is
also extensive cross-talk between Ca2+ signaling and
the adenylate cyclase-cyclic adenosine monophosphate
(cAMP)-protein kinase A (PKA) signaling pathway.
Thus, interference with Ca2+ homeostasis could play a
role in the observed chronic renal damage induced by
ifosfamide and metabolites.
The aim of the following study was to examine the ef-
fects of CAA, which is suspected to be the most important
agent in ifosfamide nephrotoxicity, on Ca2+ homeostasis
in human renal proximal tubular cells (RPTEC) in pri-
mary culture. Furthermore, the role of [Ca2+]i on CAA
toxicity in RPTEC was investigated to eventually develop
a method for prevention of renal damage which reduces
the benefits of ifosfamide therapy.
METHODS
Cell culture
RPTECs were purchased from Clonetics (Cam-
brex Bioproducts, via CellSystems, St. Katharinen,
Germany). Cells were cultivated in plastic culture
dishes (growth area 75 cm2) in Dulbecco’s modified
Eagle’s medium (DMEM)/Ham F-12, supplemented
with 1.1 g/L NaHCO3, 3.57 g/L 4-(2-hydroxyethyl)-1-
piperazineethanesulphonic acid (Hepes), 5 mg/L human
apotransferrin, 5 mg/L (bovine) insulin, 500 lg/L hy-
drocortisone, 10 lg/L mouse epidermal growth factor
(EGF), 5 lg/L sodium-selenite, 0.5% fetal calf serum
(FCS) (Biochrom, Berlin, Germany), 6.5 lg/L thyroxin,
and 500 lg/L epinephrine under standard cell culture
conditions (37◦C, 5% CO2). The medium was changed
three times a week and the cells were subcultivated
every 14 days. For measurement of [Ca2+]i cells were
seeded on thin, glass microscope coverslips coated with
poly(L)lysine (0.1 g/L) (Serva, Heidelberg, Germany).
Measurement of cytosolic-free Ca2+
Cytosolic-free Ca2+ ([Ca2+]i) was determined using
the Ca2+-sensitive dye fura-2-AM as described else-
where [13]. In brief, after serum depletion for 24 hours,
cells were incubated with Hepes-Ringer solution contain-
ing fura-2-AM in a final concentration of 5 lmol/L at
37◦C for 15 minutes. Subsequently the coverslips were
mounted on the stage of an inverted Axiovert 100 TV
microscope (40× magnification, oil immersion) (Zeiss,
Oberkochen, Germany). The fluorescence signal was
monitored at 520 nm using a band pass filter (515-565 nm)
with the excitation wavelength alternating between 334
and 380 nm using a 100 W xenon lamp and an au-
tomatic filter change device (Hamamatsu, Herrsching,
Germany). The sampling rate was one ratio every 2 sec-
onds. [Ca2+]i was calculated according to previously re-
ported methods [13], assuming a dissociation constant
(Kd) of 225 nmol/L, after subtraction of background flu-
orescence. The maximum and minimum ratios (Rmax and
Rmin, respectively) were measured after addition of cal-
ibration solutions, containing 1 lmol/L ionomycin and
1 mmol/L Ca2+ (Rmax) or 1 mmol/L ethyleneglycol-bis(b-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA)
and no Ca2+ (Rmin). Ringer solutions contained (in
mmol/L): NaCl 122.5, KCl 5.4, 0.8 MgCl2, 1.2 CaCl2,
NaH2PO4 1, Hepes 10, and D-glucose 5.5. For Ca2+-
free Ringer solution no CaCl2 was added, resulting in
free Ca2+ concentrations <10 lmol/L as determined
with Ca2+-sensitive electrodes. In Na+ free Ringer so-
lut ion, Na+ was isoosmotically replaced by N-methyl-D-
glucamine (NMDG).
Measurement of Na+/Ca2+ exchanger (NCX) activity
NCX activity was measured similar to the determi-
nation of Na+/H+ exchanger activity as previously de-
scribed [14, 15]. Extracellular Na+ (Na+o) was replaced
by NMDG. After removal of Na+o, the NCX switches
to the “Ca2+ entry” mode. By readdition of extracellu-
lar Na+, there is a rapid decline in [Ca2+]i mediated by
NCX. If the procedure was repeated twice under control
conditions, Na+-dependent Ca2+ extrusion was not dif-
ferent during the first and second maneuver (114 ± 6%)
(N = 90) (see also Table 2). Thus, results are presented as
percent of control in paired experiments. The slope of the
Ca2+ decrease (nmol ∗ L−1 ∗ second−1) was used as sur-
rogate for NCX activity. Experiments conducted in the
presence of the T-type Ca2+ channel blocker nifedipine
(10 lmol/L) and 1 mmol/L ouabain to inhibit Na+/K+-
adenosine triphosphatase (ATPase) showed similar re-
sults, as compared to the absence of inhibitors. Thus, the
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experiments were carried out without T-type Ca2+ chan-
nel and Na+/K+-ATPase inhibition.
Mn2+ quenching technique
The Mn2+ quench technique is based on the ability of
Mn2+ ions to enter the cells via Ca2+ channels, bind to
fura-2 with a higher affinity than Ca2+ and quench the
fluorescence at 365 nm excitation (isosbestic wavelength)
[16]. Hence, the decrease of fluorescence intensity in the
presence of extracellular Mn2+ reflects the entry of Mn2+
via Ca2+ channels. The experiments were carried out in
Ringer solution containing 50 lmol/L Mn2+.
Measurement of cytosolic pH (pHi)
Cytosolic pH (pHi) was measured using the fluores-
cent dye 2′,7′-bis(carboxyethyl)-5(6)-carboxyfluorescein
(BCECF-AM) as described elsewhere [14]. In brief, cells
were incubated with Hepes containing 2 lmol/L BCECF-
AM for 5 minutes. Then, the coverslips were rinsed
four times with superfusion solution to remove the dye-
containing medium. The coverslips were transferred to
the stage of an inverted Axiovert 100 TV microscope
(Zeiss) and allowed to equilibrate for 15 minutes. The
excitation light source was a 100 W mercury lamp. The ex-
citation wavelengths were 450 nm/490 nm, emission was
measured at 520 nm. After background subtraction, flu-
orescence intensity ratios were calculated. Calibration of
intracellular pH was performed as previously described
[14].
Measurement of cytosolic sodium [Na+]i
[Na+]i was measured using the fluorescent dye sodium-
binding benzofuran isophthalate (SBFI-AM) similar to
[Ca2+]i and pHi. Cells were incubated with Hepes con-
taining 5 lmol/L SBFI-AM for 15 minutes. Fluorescence
was determined at 520 nm, excitation wavelengths were
334 nm/380 nm. After background subtraction, fluores-
cence intensity ratios were calculated.
Determination of apical c-glutamyl-transpeptidase
activity
c-glutamyl-transpeptidase activity was measured using
the photometric determination of p-nitroaniline result-
ing from the c-glutamyl-transpeptidase catalyzed reac-
tion of L-c-glutamyl-p-nitroanilide and glycylglycine to
c-glutamyl-glycylglycide and p-nitroaniline [17]. Cells
were seeded in 24-well plates and serum-depleted
24 hours before the experiment. After washing three
times with Hepes-Ringer solution, cells were in-
cubated 5 and 10 minutes with reaction solution
containing 100 mmol/L Tris, 4 mmol/L L-c-glutamyl-p-
nitroanilide, and 50 mmol/L glycylglycine. Absorption of
p-nitroaniline was measured at 405 nm. E was calcu-
lated from extinction (E) (5 minutes) and E (10 minutes)
to determine brushborder c-glutamyl-transpeptidase ac-
tivity. After rinsing three times, cell were lysed with Tri-
ton X-100, centrifuged (13,000 U/min, 10 minutes) and to-
tal c-glutamyl-transpeptidase activity was measured from
cell lysate. Apical c-glutamyl-transpeptidase activity was
expressed as percent of total c-glutamyl-transpeptidase
activity.
Determination of cellular protein content
Protein content was determined with the bicinchoninic
acid (BCA) assay (Pierce, KMF Laborchemie, Sankt Au-
gustin, Germany) as described previously [18]. Cells were
grown on 24-well plates, serum-starved for 24 hours and
incubated with experimental chemicals as indicated. Af-
ter removal of culture media cells were lysed in Triton
X-100 and 15 lL aliquots of the lysates were incubated
at 37◦C for 30 minutes with 300 lL of the BCA reagent
(50 parts reagent + 1 part 4% CuSO4). Absorbance was
measured at 560 nm in a multilabel counter (Victor2)
(Wallac, Turku, Finland). Protein content was calculated
from a protein standard.
Measurement of caspase-3 activity
Caspase-3 activity was determined as described previ-
ously [18, 19]. Briefly, after washing with cold phosphate-
buffered saline (PBS), cells were lysed in 100 lL cell
lysis buffer [10 mmol/L Tris, 100 mmol/L NaCl, 1 mmol/L
ethylenediaminetetraacetic acid (EDTA), and 0.01% Tri-
ton X-100, pH 7.5) and incubated 10 minutes on ice, har-
vested, and centrifuged (16,000g for 10 minutes at 4◦C).
Then 60 lL of the supernatant were incubated 60 minutes
at 37◦C with 50 lmol/L caspase-3 substrate [acetylated- 7-
amino-4-trifluoromethyl-coumarine (Ac-DEVD-AFC)].
Finally, fluorescence of the cleaved product AFC was
measured at 400 nm excitation and 505 nm emission
wavelength in a multilabel counter (Victor2) (Wallac).
Cleaved AFC was quantified by a calibration curve using
known AFC concentrations.
DNA condensation assay
Condensation of DNA was visualized using 4′,6-
diamino-2-phenylindole (DAPI). Cells were seeded on
coverslips and incubated with CAA or vehicle for
48 hours after serum depletion for 24 hours. After wash-
ing two times with ice-cold PBS buffer (200 mmol/L NaCl,
2.7 mmol/L KCl, 8.1 mmol/L Na2HPO4, and 1.5 mmol/L
KH2PO4) cells were fixed using ice-cold methanol glacial
acetic acid (1:3) for 10 minutes. Following another wash
with PBS, cells were incubated 15 minutes with DAPI
solution (5 mg/L DAPI, 0.1% Triton X-100, 2 mmol/L
MgCl2, 100 mmol/L NaCl, and 10 mmol/L Pipes, pH6.8)
at room temperature in darkness. Cells were washed
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twice with PBS. Fluorescence was detected at 520 nm
emission and 334 nm excitation using an inverted Ax-
iovert 100 TV microscope (40× magnification, oil immer-
sion) (Zeiss).
Measurement of trypan blue exclusion
Trypan blue exclusion was determined as a marker for
loss of membrane integrity and thus necrosis, being about
as sensitive as measurement of lactate dehydrogenase
(LDH) release [18]. As described, cells were incubated
for 5 minutes with 0.2% trypan blue, washed four times
with PBS and afterwards lysed with 1% sodium dode-
cyl sulfate (SDS) in PBS. Absorbance was measured at
560 nm in a multilabel counter (Victor2) (Wallac). Pro-
tein content in the wells was determined as described
above using the BCA reagent. Interferences between try-
pan blue and the BCA measurement were negligible and
did not affect the results compared to experiments were
BCA was determined alone.
NCX-1 reverse transcription-polymerase
chain reaction (RT-PCR)
RPTEC mRNA was extracted using the ArrayGrade
mRNA Purification Kit (Superarray, Biomol, Hamburg,
Germany). Super-Script One-Step RT-PCR Kit (Invitro-
gen, Karlsruhe, Germany) was used for RT-PCR. To ex-
clude DNA contamination of the samples a second Mas-
termix was prepared and heated to 94◦C for 4 minutes
before performing RT-PCR to denature reverse tran-
scriptase. RPTEC genomic DNA prepared by phenol-
chloroform-isoamylalcohol extraction served as positive,
sterile H2O as negative controls.
NCX-1 primers were chosen according to Zhang at al
[20] (GenBank accession number NM 021097): hNCX-
1 sense primer 5′-tgtgcatctcagcaatgtca-3′; hNCX-1 anti-
sense primer 5′-ttcctcgagctccagatgtt-3′ (predicted prod-
uct size 230 bp). RT reaction was performed at 50◦C
for 30 minutes. After heating to 94◦C for 2 minutes, 35
PCR cycles (94◦C, 1 minute; 53◦C, 1 minute; and 72◦C,
1 minute) were executed, followed by final extension at
72◦C for 10 minutes. Afterward, the samples were ana-
lyzed by electrophoresis in 1.5% agarose gel and stained
with ethidium bromide.
Determination of cell number
Cell number was determined using a Z2 series Coul-
ter Counter. Cells were seeded on plastic dishes and
grown to confluence (approximately 100,000 cells/cm2).
Cells were made quiescent by removal of additives
and serum for 24 hours. The experiments were car-
ried out in medium without additives to insure that
changes in cell number were solely dependent on addition
of CAA and 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-
tetraacetic acid acetoxymethyl ester (BAPTA-AM).
Materials
Ionomycin, monensine, thapsigargin, CAA, phor-
bol 12-myristate 13-acetate (PMA), forskolin, and an-
giotensin II (Ang II) were purchased from Sigma
(Deisenhofen, Germany). Bisindolylmaleimide I (BIM I)
and H-89 were obtained from Alexis (Gru¨nberg,
Germany). BAPTA-AM, fura-2-AM, BCECF-AM, and
SBFI-AM were obtained from Molecular Probes
(Leiden, The Netherlands). All other chemicals were of
analytical grade and obtained from Merck (Darmstadt,
Germany).
Statistics
The data are presented as mean values ± SEM. Signifi-
cance of differences was tested by the paired or unpaired
Student t test or analysis of variance (ANOVA) as appro-
priate. Differences were considered significant when P <
0.05. Cells from at least two different passages were used
for each experimental series. Ca2+, pH, and Na+ mea-
surements were performed using at least four coverslips
with cells from at least two different passage numbers;
N represents the number of cells or tissue culture dishes
investigated.
RESULTS
Renal proximal tubular characteristics of RPTEC
Apical expression of c-glutamyl-transpeptidase. One
characteristic of renal proximal tubule cells is api-
cal expression of c-glutamyl-transpeptidase in abun-
dance. Mean total c-glutamyl-transpeptidase activity was
268.4 ± 16.5 U/mg protein. Figure 1 shows that the per-
centage of apical c-glutamyl-transpeptidase in RPTEC is
dependent on passage number. The ratio apical/total c-
glutamyl-transpeptidase was highest between passages 5
and 9, so that preferentially these passages were used for
experiments.
Calcium response to Ang II. Renal proximal tubule
cells posses an intrinsic renin-angiotensin system, so that
proximal tubule cells should respond to Ang II. Most of
Ang II effects are mediated via the angiotensin type 1
(AT1) receptor resulting in inositol-1,4,5 triphosphate
(IP3) formation and release of Ca2+ from intracellular
stores. Table 1 shows that the Ca2+ response of RPTEC
was also passage dependent, indicating that proximal
tubular differentiation increased in passages >4.
Effects of CAA on cytosolic Ca2+ in RPTEC
CAA increases baseline Ca2+ in RPTEC. CAA in-
duced a dose-dependent increase in cytosolic Ca2+ con-
centration in RPTEC (Fig. 2). This effect was not
reversible within minutes after removal of CAA from
the bath solution. Baseline [Ca2+]i in RPTEC was 75 ±
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Fig. 1. Apical distribution of c-glutamyl-transpeptidase (cGT) in hu-
man renal proximal tubule cells (RPTEC) (N = 6 to 12) changes with
passage number. Human embryonic kidney 293 (HEK-293) cells (pas-
sage 42) were used as negative control cells with no proximal tubular
phenotype (N = 6).
Table 1. [Ca2+]i (nmol/L) induced by 100 nmol/L angiotensin II
(Ang II) in human renal proximal tubule cells (RPTEC) passage 4
and 7
Passage 4 (N = 43) 56.6 ± 10.8
Passage 7 (N = 22) 263.1 ± 46.1
3 nmol/L (N = 189). After 5 minutes’ exposure to
15 lmol/L CAA, [Ca2+]i rose to 140 ± 8 nmol/L (N =
51). The threshold dose was as low as 15 nmol/L. The
CAA effect was near maximum at 15 lmol/L. For further
experiments CAA concentrations of 1.5 and 15 lmol/L
were used, since they closely resemble the concentrations
occurring during ifosfamide treatment [21].
The Ca2+ effect of CAA is dependent on extracellular
Ca2+ but CAA does not enhance Ca2+ entry. Exposure
of RPTEC to nominally Ca2+-free Ringer solution (free
Ca2+ <10 lmol/L) reduced intracellular-free Ca2+ from
76 ± 10 nmol/L to 53 ± 7 nmol/L (N = 23) (P < 0.05).
Under these conditions, CAA was no longer able to in-
duce baseline shifts in [Ca2+]i (Fig. 3). The inhibitor
of sarco-/endoplasmic reticulum Ca2+-ATPase (SERCA)
thapsigargin was used as positive control for Ca2+ re-
lease from intracellular stores (to show that prolonged
exposure to low [Ca2+]o did not deplete intracellular
stores). These results points toward a role of Ca2+ in-
flux for CAA-induced Ca2+ increase. Using the Mn2+
quench-technique, opening of Ca2+ channels was investi-
gated. Since Mn2+ ions enter the cells via Ca2+ channels,
opening of these channels would accelerate quenching
of fura-2 fluorescence by Mn2+. As depicted in Figure 4,
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Fig. 2. Effect of chloroacetaldehyde (CAA). (A) Original tracing of
the effect of CAA on intracellular Ca2+ in human renal proximal tubule
cells (RPTECs). (B) CAA increased baseline Ca2+ in RPTEC dose-
dependently with a maximal effect at 15 lmol/L. ∗P < 0.05 vs. control.
CAA did not enhance Mn2+ entry. The ionophore iono-
mycin was used as a positive control, depolarization by
20 mmol/L KCl as negative control. Ionomycin enables
enhanced Mn2+ entry, resulting in enhanced quenching of
fura-2 fluorescence, whereas depolarization slows Mn2+
quenching by reduced channel open probability.
Inﬂuence of CAA on cellular Ca2+ extrusion mech-
anisms. Another way to induce an increase of
intracellular-free Ca2+ dependent on extracellular Ca2+
would be to inhibit extrusion of intracellular Ca2+ via the
plasma membrane, which is in equilibrium with constitu-
tive Ca2+ entry. Removal of extracellular Ca2+ abolishes
Ca2+ leakage into the cell and the inhibition of an ex-
trusion system would no longer be detectable. There are
two main mechanisms by which cells extrude Ca2+ across
the plasma membrane: Plasma membrane Ca2+-ATPases
(PMCA) and NCX proteins [22, 23].
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Fig. 3. Effect of lowering extracellular Ca2+ below 10 lmol/L. (A)
There was a decrease of [Ca2+]i in human renal proximal tubule cells
(RPTEC) and abolished the effect of chloroacetaldehyde (CAA). (B)
Store depletion with 100 nmol/L thapsigargin (TG) still produced a
significant Ca2+ response under these conditions.
The PMCA. Since there is evidence for inhibition
of PMCA by the nephrotoxic immunosuppressant cy-
closporine A [24], we tested if CAA affected the pattern
of Ca2+ mobilization from internal stores using thapsi-
gargin, an inhibitor of SERCA. Kinetics of Ca2+ extru-
sion were analyzed by fitting the data to an exponential
equation:
y = y0 + ae−bx
where y0 is plateau Ca2+ concentration; a is peak Ca2+
concentration; and b is time constant. After exposure to
100 nmol/L thapsigargin [Ca2+]i peaked after store de-
pletion (peak concentration 526 ± 131 nmol/L in control
cells and 591 ± 145 nmol/L in CAA-treated cells) and de-
creased to an elevated plateau (plateau 116 ± 9 nmol/L in
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Fig. 4. Addition of 50 lmol/L Mn2+ led to a decrease in fura-2 fluo-
rescence by excitation with 365 nm (isosbestic wavelength). Chloroac-
etaldehyde (CAA) did not influence the time course of Mn2+ entry.
High extracellular K+ (20 mmol/L) was used as negative, 1 lmol/L ion-
omycin (iono) as positive control.
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Fig. 5. Measured and calculated Ca2+ peak and plateau concentra-
tions after store-depletion by 100 nmol/L thapsigargin (control N = 50;
chloroacetaldehyde (CAA) N = 44). Inset, Time constant of Ca2+ ex-
trusion under control conditions and CAA exposure. The Ca2+ peak as
well as the area under the curve (data not shown) were slightly but not
significantly increased in CAA-exposed cells.
control cells and 120 ± 10 nmol/L in CAA-treated cells).
The results of the experiments are presented in Figure 5,
the calculated peak values being slightly lower than ac-
tually measured (Fig. 5). Time constants were 0.0498 ±
0.0088 seconds−1 (control) and 0.0579 ± 0.0139 seconds−1
(CAA). Taken together, there was no significant differ-
ence between control cells and CAA-treated cells in Ca2+
extrusion after thapsigargin challenge. According to the
literature, it was expected to uncover inhibition of PMCA
by the chosen experimental design [24]. Since the NCX
pathway for Ca2+ efflux has lower affinity, but higher
turnover rate than PMCA [22], incomplete inhibition of
NCX would not necessarily be detectable in this setting.
The NCX. To test NCX as a Ca2+ extrusion mecha-
nism, Na+ was removed from the bath solution and isoos-
motically replaced by NMDG. After Na+ replacement
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Fig. 6. Original tracings of [Ca2+]i in human renal proximal tubule cells (RPTECs). Na
+ removal switched the Na+/Ca2+ exchanger to Ca2+ entry
mode, leading to an increase of [Ca2+]i. By readdition of extracellular sodium, [Ca2+]i decreased rapidly due to Ca2+ exit mode of the exchanger.
Under control conditions repeated Na+ removal left the slope unaltered (A). Chloroacetaldehyde (CAA) exposure reduced Na+-dependent
Ca2+ extrusion in RPTECs (B). (C) [Ca2+]i (nmol ∗ L−1 ∗ second−1) vs. [Ca2+]i (nmol/L) for control and CAA-exposed cells. CAA reduced
Na+-dependent Ca2+ extrusion resulting in a right shift of the concentration-response curve for Na+/Ca2+ exchange. ∗P < 0.05 vs. control.
RPTEC responded with a rise in [Ca2+]i, as shown in
Figure 6A and B. This effect was not observed when the
maneuver is carried out in nominally Ca2+-free extracel-
lular solution (data not shown). Readdition of extracel-
lular Na+ led to a rapid decrease in [Ca2+]i. There was
no significant difference when the experiments were car-
ried out in presence of 1 mmol/L ouabain and 10 lmol/L
nifedipine (data not shown). A second repetition of the
maneuver did not alter the Ca2+ plateau after Na+ re-
moval nor the slope of Ca2+ decrease under control con-
ditions (Fig. 6A) (Table 2). Thus, paired experiments were
carried out, using Na+ removal/readdition for two times
(first time control, second time control, CAA, and/or
modulators). Addition of 15 lmol/L CAA reduced Na+-
dependent Ca2+ extrusion to 65 ± 4% of control (Fig. 6B)
(Table 2). These data are consistent with an inhibition of
NCX by CAA. Figure 6C shows a CAA-induced right
shift in the dose-response curve for Na+-dependent Ca2+
extrusion indicating that the inhibition by CAA is not due
to a reduced Ca2+ plateau, but impairment of Ca2+ exit.
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Table 2. Na+ removal/readdition produced a similar Ca2+ plateau and Ca2+ decrease if performed twice under control conditions
(control/control)
Plateau 1 Slope 1 nmol ∗ Plateau 2 Slope 2 nmol ∗
nmol/L L−1 ∗ second−1 mnol/L L−1 ∗ second−1
Control/control (N = 90) 441.8 ± 64.5 25.5 ± 3.6 381.8 ± 45.6 26.3 ± 2.4
Control/chloroacetaldehyde (N = 82) 454.1 ± 77.7 27.4 ± 4.0 273.7 ± 40.6a 12.7 ± 1.8a
aWhen 15 lmol/L chloroacetaldehyde (CAA) were present the second time, it exerted a marked inhibition of Ca2+ extrusion (control/CAA) (plateau 2 and slope 2).
200 bp
M – + 1 2 1 2 + – M
+ RT – RT
Fig. 7. Reverse transcription-polymerase chain reaction (RT-PCR) and PCR of human renal proximal tubule cells (RPTECs) mRNA-preparations
revealed Na+/Ca2+ exchanger mRNA expression in human renal proximal tubule cells (RPTECs). Abbreviations are: M, DNA molecular weight
marker; –, H2O as negative control; +, RPTEC genomic DNA as positive control; 1 and 2, mRNA preparations of RPTEC; +RT, RT-PCR, 35
cycles; –RT, = RT-PCR, 35 cycles after denaturation of RT by incubating the Mastermix 4 minutes at 94◦C. Representative of three independent
experiments.
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Fig. 8. Effects of modulators of protein kinase C (PKC) and protein kinase A (PKA) on Na+/Ca2+ exchange (NCX) activity in human renal
proximal tubule cells (RPTECs). Inhibition of PKC by 100 nmol/L bisindolylmaleimide I (BIM) stimulated activation of PKC by 100 nmol/L
phorbol 12-myristate 13-acetate (PMA) decreased NCX. Activation of PKA by 10 lmol/L forskolin or 100 lmol/L dibutyryl-cyclic adenosine
monophosphate (cAMP) reduced Na+-dependent Ca2+ extrusion, whereas inhibition of PKA by 500 nmol/L H-89 showed no effect. Modulation
of PKA activity in both directions blunted the effect of chloroacetaldehyde (CAA) on NCX. n.s. is not significant. ∗P < 0.05 vs. control)
Since there are contradictory data about the expres-
sion of NCX proteins in renal proximal tubule epithelial
cells [23, 25, 26], we used RT-PCR to test whether human
RPTEC show not only functional characteristics of NCX,
but also express NCX-1-mRNA. Figure 7 shows the re-
sults of a representative PCR/RT-PCR for human NCX-1
protein. There are bands of the expected size (230 bp) in
both samples (1 and 2 +RT) that could not be reproduced
when reverse transcriptase was denatured by heating the
Mastermix to 94◦C for 4 minutes before cDNA synthesis
(1 and 2 –RT). These results indicate that RPTEC express
NCX both functionally and on the mRNA level.
To further elucidate the mechanisms by which CAA
reduces NCX activity, regulation by PKA and PKC was
examined. As depicted in Figure 8, inhibition of PKC
by BIM, 100 nmol/L, 10-minute incubation, increased
NCX activity to 154 ± 14% (N = 27) of control. In
the presence of BIM the inhibitory effect of 15 lmol/L
CAA was still present (54 ± 9%) (N = 32). Stimulation
of PKC by 5-minute incubation with the phorbolester
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PMA (100 nmol/L) slowed Na+-dependent Ca2+ extru-
sion (55 ± 8%) (N = 31), but this effect could still be
enhanced by CAA (26 ± 3%) (N = 16). PKA stimula-
tion with 10 lmol/L forskolin (5 minutes), which increases
intracellular cAMP levels, reduced NCX activity to 53 ±
8% of control (N = 19). In contrast to PMA, the effect
of forskolin could not be amplified by CAA (62 ± 8%)
(N = 11). The same was observed when PKA was acti-
vated by the direct agonist dibutyryl-cAMP (100 lmol/L).
Dibutyryl–cAMP inhibited NCX activity by 71 ± 2%.of
control (N = 46). There was no further inhibition by
15 lmol/L CAA (dibutyryl-cAMP + CAA 75 ± 6% of
control) (N = 41). H-89 (1 lmol/L), a specific inhibitor of
PKA [27], did not influence NCX activity after 10 min-
utes’ incubation (105 ± 11%) (N = 14), yet the inhibitory
effect of CAA was abolished (99 ± 8%) (N = 31), when
H-89 and CAA were coadministered. Thus, the inhibition
of NCX by CAA seems to be dependent on PKA activity.
Effects of CAA on intracellular sodium and pH ([Na+]i
and [pH]i). Since there are reports that CAA expo-
sure inhibits the Na+/K+-ATPase [11, 12], intracellular
sodium was measured to exclude that the inhibition of
NCX by CAA is caused by intracellular accumulation
of sodium. Therefore, the sodium-sensitive dye SBFI
was used. Exposure to 15 lmol/L CAA for 5 minutes
did not alter 334/380 nm ratio (control 2.27 ± 0.09)
(N = 36) (CAA 2.32 ± 0.09) (N = 36) (P = 0.28),
whereas 1 mmol/L ouabain and the ionophore monen-
sine (10 lmol/L) caused a substantial increase in SBFI
fluorescence ratio (ouabain 2.41 ± 0.09) (P < 0.05) (mo-
nensine 3.0 ± 0.12) (P < 0.05). Therefore, inhibition of
Na+/K+-ATPase by CAA seems not to play a role within
the time frame used for Na+ removal/readdition exper-
iments. To elucidate possible interference of CAA with
intracellular pH, the pH-sensitive dye BCECF-AM was
used. Resting pHi of RPTEC was 6.95 ± 0.05 (N = 12)
and pH evoked by CAA was –0.06 ± 0.02 (N = 11) (P =
0.11). To test whether Na+/H+ exchange was affected, the
NH4Cl prepulse was used. After exposure to 20 mmol/L
NH4Cl, pHi rose to 7.90 ± 0.34 and decreased to 6.22 ±
0.02 upon removal of extracellular Na+. Readdition of
extracellular Na+ induced a recovery of pHi which was
not affected by 15 lmol/L CAA (recovery control 0.22 ±
0.04 U/min; recovery CAA 0.20 ± 0.10 U/min) (N = 12
and 11, respectively) (P = 0.46). These experiments were
performed to exclude possible interference of CAA with
Na+ and pH homeosteasis in the concentration and time
frame used for NCX experiments.
Toxicity of CAA in RPTEC
Effects of CAA on cell survival. Figure 9 presents the
effects of 72 hours’ incubation with different concentra-
tions of CAA on RPTEC protein content as a crude mea-
sure of cell number (absolute value of control protein
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Fig. 9. Long-term incubation (72 hours) with different chloroacetalde-
hyde (CAA) concentrations. Concentrations ≥ 15 lmol/L led to a signif-
icant decrease of renal proximal tubule cell (RPTEC) protein content.
25.8 ± 2.5 lg/well; 48 hours’ incubation with 15 lmol/L
CAA reduced cell number to 77 ± 4% of control). Pro-
tein content of RPTEC was not significantly reduced by
1.5 lmol/L CAA or lower concentrations. The prodrug
ifosfamide did not alter RPTEC protein content (105 ±
9% of control) (N = 6) supporting the relevance of drug
activation and generation of toxic metabolites. CAA ex-
erted time-dependent toxicity on RPTEC as well (data
not shown).
There are two distinct mechanisms that can lead to cell
death and therefore reduction in cellular protein: necrosis
and apoptosis. To discriminate, whether protein loss in-
duced by CAA is due to necrosis or apoptosis, activity of
caspase-3, a key enzyme in the apoptotic pathway, was de-
termined, as well as exclusion of trypan blue, an indicator
for decreased membrane permeability occurring during
necrotic cell death [18]. After 48 hours of incubation with
15 lmol/L CAA, uptake of trypan blue was significantly
increased to 148 ± 13% of control (Fig. 10A). Similar re-
sults were obtained for 24 and 72 hours’ incubation (data
not shown). CAA also induced cell swelling and cytoplas-
mic blebbing in RPTEC as shown in Figure 10B and C.
Twenty-four–hour incubation with 15 lmol/L CAA did
not result in increased caspase-3 activity (109 ± 3% of
control) (N = 3) (Fig. 10D), as an indicator for apopto-
sis. Furthermore, there were no signs of enhanced DNA
condensation after 48 hours’ incubation with 15 lmol/L
CAA detectable by DAPI staining (Fig. 10E and F). Thus,
there was no evidence for increased apoptosis induced by
CAA. These results indicate that protein loss following
CAA exposure for 24 to 72 hours is mainly due to induc-
tion of necrosis in RPTEC.
The role of intracellular free Ca2+ and PKA in CAA
toxicity. To test whether CAA-induced necrosis is de-
pendent on the observed changes in baseline [Ca2+]i,
cells were incubated with the intracellular Ca2+ chelator
BAPTA-AM, 50 lmol/L. As seen in Figure 11, BAPTA-
AM itself did not affect protein content and cell number,
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Fig. 10. Effect of chloroacetaldehyde
(CAA) incubations. (A) Forty-eight hours’
incubation with 15 and 150 lmol/L CAA in-
duced a reduction of cell membrane integrity,
shown by increased uptake of trypan blue.
∗P < 0.05 vs. control. (B and C) Morphologic
changes in renal proximal tubule cells
(RPTECs) after 48 hours’ incubation with
15 lmol/L CAA. (D) Caspase-3 activity was
not increased after 24 hours’ incubation with
15 lmol/L CAA, indicating a subordinate
role of apoptosis in CAA-induced cell death.
(E and F) Confirming the caspase-3 data,
4′,6-diamino-2-phenylindol (DAPI) staining
showed no increased DNA condensation
after 48 hours’ incubation with 15 lmol/L
CAA compared to controls. Representative
of three independent experiments.
but prevented the effect of 15 lmol/L CAA. Notwith-
standing the toxicity of 150 lmol/L CAA was unaffected
by chelation of intracellular Ca2+. In order to test suffi-
cient clamping of [Ca2+]i by 50 lmol/L BAPTA-AM in
presence of 150 lmol/L CAA, fura-2 measurements were
performed. Under control conditions, fura-2 ratio was in-
creased from 1.59 ± 0.02 to 3.36 ± 0.81 (N = 16) (P <
0.05 vs. control). After 5 minutes exposure to 150 lmol/L
CAA, 2 lmol/L ionomycin induced a further increase to
8.12 ± 1.51 (N = 16). Fifteen minutes’ incubation with
50 lmol/L BAPTA-AM blunted the effect of 150 lmol/L
CAA on fura-2 ratio (BAPTA + CAA 1.53 ± 0.06) (N =
18) (P = 0.3 vs. control) and markedly diminished the
effect of ionomycin (fura-2 ratio 1.80 ± 0.11) (N = 18)
(P < 0.05 vs. control).
Since the effect of CAA on NCX could be inhib-
ited by PKA modulation, a possible protection against
CAA toxicity by the PKA inhibitor H-89 was investi-
gated. Protein content of RPTEC after 1 hour preincu-
bation and 48 hours’ exposure to 0.5 lmol/L H-89 was
13.4 ± 2.3 lg/well (N = 20). One hour preincubation with
0.5 lmol/L H-89 and 48 hours’ exposure to 15 lmol/L
CAA and 0.5 lmol/L H-89 resulted in a protein content
of 11.5 ± 1.9 lg/well (N = 20) (P = 0.2 vs. H-89 alone).
DISCUSSION
The data obtained from fura-2 measurements indicate
that CAA is capable to disturb intracellular Ca2+ home-
ostasis in human RPTEC. The effect was a sustained shift
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Fig. 11. (A) Chelation of intracellular free Ca2+ by 1,2-bis(2-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid acetoxymethyl es-
ter (BAPTA-AM) (50 lmol/L) completely abolished the effect of
15 lmol/L chloroacetaldehyde (CAA) on renal proximal tubule cell
(RPTEC) protein content after 48 hours of incubation. The toxicity of
150 lmol/L CAA remained unchanged by BAPTA-AM. (B) The de-
crease in cell number caused by 15 lmol/L CAA was also inhibited by
50 lmol/L BAPTA-AM.
in baseline [Ca2+]i that could already be observed with
nontoxic concentrations of CAA. The baseline Ca2+ in-
crease was dependent on extracellular Ca2+. Yet, there
was no evidence for Ca2+ influx via Mn2+-permeable ion
channels. CAA did not significantly change the kinetics of
Ca2+ removal after depletion of intracellular stores by the
SERCA inhibitor thapsigargin. However, the experimen-
tal setup does not sincerely discriminate between the two
major extrusion mechanisms, PMCAs and NCX. Accord-
ing to literature, NCX represents a system with low affin-
ity, but high turnover rate, whereas PMCAs seem to be
mainly responsible for “fine tuning,” since they show high
affinity but a lower turnover rate [22]. As described in
literature, PMCA inhibition is detectable after thapsigar-
gin challenge by an increased Ca2+ plateau [24]. Since the
Ca2+ plateau following thapsigarin challenge lies well in
the range of the fura-2 Kd for Ca2+, even smaller changes
should be detectable, making an inhibition of PMCA by
CAA unlikely.
The NCX operates as a secondary active transport sys-
tem powered by the Na+/K+-ATPase. There are three
known isoforms of the protein expressed in multiple
tissue-specific splice variants [28]. The transporter me-
diates electrogenic countertransport of 3 Na+ ions and
1 Ca2+ ion [22, 28]. Under basal conditions it generally
operates in the “Ca2+ exit mode,” but the exchange can
be reversed by removal of extracellular Na+. As seen
in Figure 6A and B, replacement of extracellular Na+
by NMDG led to an increase in [Ca2+]i. Readdition of
extracellular Na+ rapidly decreased [Ca2+]i by maximal
activation of NCX. CAA reduced the velocity of Na+-
dependent [Ca2+]i decrease, indicating an inhibition of
NCX. NCX activity is controlled by the electrochemi-
cal gradient for Na+ and Ca2+ and membrane potential.
Furthermore, [Na+]i, [Ca2+]i, and pHi exert regulatory
effects on the protein [22, 28–31]. As described in the
Results section, there was no evidence for interference
of CAA with [Na+]i and pHi in the timeframe and con-
centration investigated. Regulation of NCX by PKA and
PKC has also been described, whereas different effects
have been shown in different experimental settings [15,
32–34]. Under the conditions in our setup, inhibition of
PKC by 100 nmol/L BIM increased Na+-dependent Ca2+
extrusion, while activation of PKC by short-term incu-
bation with 100 nmol/L PMA decreased NCX activity
(Fig. 8). The inhibitory effect of CAA was still present,
independent of inhibition or activation of PKC. Thus the
effect of CAA on NCX seems not to be mediated by PKC.
PKA inhibition by H-89 did not influence the kinetics
of Na+-induced Ca2+ removal in RPTEC, but abolished
CAA-induced inhibition. Activation of adenylylcyclase
and thus PKA by forskolin led to a decreased NCX activ-
ity. Under these conditions no further inhibiting action
of CAA could be observed. A direct agonist of PKA,
dibutryl-cAMP (100 lmol/L) also reduced NCX. Again,
CAA exerted no additional inhibitiory action on NCX.
Thus, we conclude that CAA inhibits NCX via PKA. If
PKA is activated maximally by other agents, CAA has
no further effect on PKA and therefore also on NCX. On
the other hand, if PKA is inhibited, the signaling pathway
for CAA-induced inhibition of NCX is blocked. The de-
pendence on PKA points toward an interaction of CAA
with either cAMP-PKA pathway or the regulatory site for
PKA on the NCX protein. These effects could be due to
the property of CAA to react with sulfhydryl groups [3].
Modification of PKA activity by sulfhydryl reagents has
been described [35, 36]. Furthermore, there is evidence
for inhibition of the NCX by covalent modification of
cysteine residues [37].
CAA toxicity in RPTEC was mainly due to necrotic cell
death, leading to reduced protein content and disruption
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of membrane integrity. The necrotic effect of CAA was at
least in part dependent on intracellular free Ca2+, since
BAPTA-AM, an intracellular Ca2+ chelator abolished
the detrimental effect of 15 lmol/L CAA (Fig. 11). The ef-
fects of CAA on intracellular free Ca2+ reach their max-
imum ∼15 lmol/L CAA, whereas CAA l 150 lmol/L
seems to evoke other “unspecific” effects. Consequently,
Ca2+ chelation does no longer protect against toxicity.
As described in the Results section, 50 lmol/L BAPTA-
AM were capable in completely abolishing the increase
in [Ca2+]i induced by 150 lmol/L CAA as well as dramat-
ically reducing the effect of a maximal stimulus for Ca2+
increase (2 lmol/L ionomycin).Thus, 50 lmol/L BAPTA-
AM should sufficiently clamp intracellular free Ca2+ to
prevent Ca2+-mediated toxicity.
Since the increased [Ca2+]i due to CAA exposure
is likely caused by PKA-dependent inhibition of NCX,
PKA inhibition should likewise prevent CAA toxicity.
After 1 hour preincubation with 0.5 lmol/L H-89 fol-
lowed by exposure to H-89 alone and H-89 plus 15 lmol/L
CAA, there was no significant difference in protein con-
tent between H-89 alone and H-89 plus CAA, indicating a
protective effect of PKA inhibition. However, long-term
inhibition of PKA itself reduces viability and protein con-
tent due to the importance of PKA for cellular function.
CAA is known to react with thiol groups and depletion
of cellular or plasma glutathione content is frequently ob-
served in vitro and in vivo [21, 38]. In contrast to the
clinical observations, administration of thiol donators,
MESNA or amifostine can protect cells from CAA toxic-
ity in vitro [10], indicating a role of sulfhydryl (SH) groups
in the pathogenesis of ifosfamide nephropathy. The ob-
served Ca2+-dependent toxicity of CAA in a concentra-
tion of 15 lmol can be attributed to different sensitiv-
ity of different cellular proteins to modification of thiol
groups. For example, proteins with cysteine residues in
the catalytic center or in regulatory domains should ex-
hibit higher sensitivity to CAA.
CONCLUSION
Our data point toward a role for impaired intracellu-
lar Ca2+ homeostasis for the nephrotoxic effect of CAA
in concentrations occurring during ifosfamide therapy.
This is a rather specific effect at CAA concentrations
∼15 lmol/L. It has to be examined further if the effects
of PKA modulators on CAA-induced NCX inhibition
have influence on CAA toxicity, in order to find an in-
hibitor that abolishes CAA action, but does not exert
toxic effects itself. Furthermore cellular cAMP content
and PKA activity in response to CAA have to be mea-
sured. The aim of further studies will be to determine the
effects of CAA on protein function by modification of SH
residues as well as a further examination of the effects of
Ca2+ responses to CAA at subnecrotic concentrations.
These effects could lead to chronic dysregulation of cel-
lular function, finally resulting in chronic nephropathy.
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